For some patients with non-small lung cancer, chemotherapy isn’t the
most effective treatment option. But based on a tumor’s molecular
profile or biomarker testing results, lung cancer treatment can be
customized to target the tumor’s unique cellular
characteristics.
Xổ số miền bắc thứ 4 hàng tuần We talked with Anne Tsao, M.D., to
understand what non-small cell lung cancer patients should know about
molecular profiling, including what tests they may need...
We’ve all felt uncertain at times during the COVID-19 pandemic. Do I have the coronavirus? Should I get tested? Do I need to quarantine?
Xổ số miền bắc thứ 4 hàng tuầnHoliday celebrations look a lot different this year because of the coronavirus (COVID-19) pandemic. It’s a difficult time for everyone, but...
Multiple myeloma is a cancer that develops in a type of white blood cell called plasma cells. Normally, these cells help us make antibodies to fight infection. But when something goes wrong during cell division, they can live forever.
Some patients live with multiple myeloma for years without any negative effects. This is called smoldering myeloma. But eventually the myeloma cells can make things go haywire in the body, affecting...
B-cell lymphoma isn’t one disease. There are about 63 subtypes, with diffuse large B-cell lymphoma (DLBCL) being the most common. A chemotherapy...
New and better cancer treatments are discovered through clinical trials. By joining one, patients get access to the most cutting-edge treatments...
Xổ số miền bắc thứ 4 hàng tuầnFirst emerging almost three decades ago, monoclonal antibodies are changing the way doctors treat cancer and other illnesses, including COVID...
Xổ số miền bắc thứ 4 hàng tuầnCAR T cell therapy has changed the way aggressive B-cell lymphoma is treated. Previously, when patients had a second recurrence after receiving...
When found early, breast cancer can often be treated successfully. “90-97% of patients with early stage breast cancer are alive and well even...
Xổ số miền bắc thứ 4 hàng tuầnClinical trials are how progress is made in medicine. “They’re really essential to drive our ability to deliver better cancer care,” says...